Gene · 1540
Papers3,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux. | Exp Hematol Oncol | 2025 | 40012003 | PubTator, text mining | PubMed |
| Ablation of the deubiquitinating enzyme cylindromatosis (CYLD) augments STAT1-mediated M1 macrophage polarization and fosters Staphylococcus aureus control. | Front Immunol | 2025 | 39958342 | PubTator, text mining | PubMed |
| Role of CYLD in brain physiology and pathology. | J Mol Med (Berl) | 2025 | 39945824 | PubTator, text mining | PubMed |
| Novel Inlay Methodology with Thermoplastic and Heating System for Durable Road Markings. | Polymers (Basel) | 2025 | 39940563 | PubTator, text mining | PubMed |
| Insights on the crosstalk among different cell death mechanisms. | Cell Death Discov | 2025 | 39929794 | PubTator, text mining | PubMed |
| Truncating CYLD Pathogenic Variants in CYLD Cutaneous Syndrome Distinctly Influence CYLD Proteostasis and NF-κB Signaling. | J Invest Dermatol | 2025 | 39924051 | PubTator, text mining | PubMed |
| Porcine epidemic diarrhea coronavirus infection activates caspase-8 to enhance innate immunity by blocking CYLD-mediated deubiquitination of RIG-I. | Virology | 2025 | 39908775 | PubTator, text mining | PubMed |
| Metastatic malignant cylindroma arising on a background of digenic inheritance of BRCA2 and CYLD pathogenic variants targeted with PARP inhibition. | Clin Exp Dermatol | 2025 | 39908333 | PubTator, text mining | PubMed |
| CYLD novel splicing mutation in a patient with CYLD cutaneous syndrome with basal cell carcinomas. | J Dermatol | 2025 | 39716479 | PubTator, text mining | PubMed |
| Glutamatergic CYLD deletion leads to aberrant excitatory activity in the basolateral amygdala: association with enhanced cued fear expression. | Neural Regen Res | 2025 | 39715097 | PubTator, text mining | PubMed |
| Exosomes secreted from M2-polarized macrophages inhibit osteoclast differentiation via CYLD. | Tissue Cell | 2025 | 39671756 | PubTator, text mining | PubMed |
| A cross-sectional observational study of quality of life in adult short bowel syndrome patients: What role does autologous gut reconstruction play? | Nutr Clin Pract | 2025 | 39667941 | PubTator, text mining | PubMed |
| Ubiquitin-Proteasome System in Periodontitis: Mechanisms and Clinical Implications. | Cell Prolif | 2025 | 39626954 | PubTator, text mining | PubMed |
| A mechanism for hypoxia-induced inflammatory cell death in cancer. | Nature | 2025 | 39506105 | PubTator, text mining | PubMed |
| Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma. | Br J Dermatol | 2025 | 39392932 | PubTator, text mining | PubMed |
| CYLD Alterations Are Associated With Metastasis and Poor Prognosis in Human Papilloma Virus-Positive Head and Neck Cancer. | Head Neck | 2025 | 39347568 | PubTator, text mining | PubMed |
| Exosomal MiR-653-3p Alleviates Hypoxic-Ischemic Brain Damage via the TRIM21/p62/Nrf2/CYLD Axis. | Mol Neurobiol | 2025 | 39298103 | PubTator, text mining | PubMed |
| Combining single-cell RNA sequencing and network pharmacology to explore the target of cangfu daotan decoction in the treatment of obese polycystic ovary syndrome from an immune perspective. | Front Pharmacol | 2024 | 39539629 | PubTator, text mining | PubMed |
| TRIM47 drives gastric cancer cell proliferation and invasion by regulating CYLD protein stability. | Biol Direct | 2024 | 39516831 | PubTator, text mining | PubMed |
| A novel step-by-step teaching method improves training outcomes in transvaginal ultrasound for postgraduate reproductive medicine students: an exploratory randomized controlled study. | BMC Med Educ | 2024 | 39508256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1540/papers?page=7